After years of type 2 diabetes, red blood cells may quietly turn against the heart—offering a new clue for spotting danger ...

The global microRNA market is projected to reach USD 3.22 billion by 2027, according to the Ambulance Services Market Report provided by Report Ocean. This report offers a comprehensive analysis of ...

Glioblastoma (GBM) is the most common and highly aggressive primary brain tumor in adults. MicroRNAs (miRNAs) are pleiotropic post-transcriptional regulators of oncogenic pathways, and frequently lose ...

The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska ...

The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood ...

The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the ...

TransCode Therapeutics ( ($RNAZ) ) just unveiled an update. On January 6, 2026, TransCode Therapeutics announced the publication in the Journal of ...

Researchers in Sweden recovered RNA from a 130-year-old Tasmanian tiger, allowing them to identify which genes were active in its tissues before extinction.

Publishes Preclinical Data Supporting TTX-MC138 For Glioblastoma. TransCode Therapeutics (NASDAQ: RNAZ) announced the publication of peer-reviewed preclinical research supporting the use of its lead ...

Despite setbacks, scientists around the world produced amazing discoveries every day, some of which made a big splash while ...